BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 223 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $23,714,941 | +97.7% | 220,031 | +74.0% | 0.01% | +83.3% |
Q1 2024 | $11,996,659 | -8.9% | 126,467 | -11.5% | 0.01% | -14.3% |
Q4 2023 | $13,175,100 | +217.7% | 142,835 | +73.0% | 0.01% | +133.3% |
Q3 2023 | $4,146,515 | -16.7% | 82,567 | +4.8% | 0.00% | 0.0% |
Q2 2023 | $4,977,758 | +3.4% | 78,762 | -26.4% | 0.00% | 0.0% |
Q1 2023 | $4,814,290 | +29.0% | 107,008 | +25.6% | 0.00% | +50.0% |
Q4 2022 | $3,733,357 | -69.4% | 85,217 | -54.0% | 0.00% | -71.4% |
Q3 2022 | $12,217,000 | +24.3% | 185,412 | -4.7% | 0.01% | +40.0% |
Q2 2022 | $9,831,000 | -22.3% | 194,641 | -1.7% | 0.01% | -16.7% |
Q1 2022 | $12,652,000 | -41.4% | 198,067 | -1.7% | 0.01% | -40.0% |
Q4 2021 | $21,581,000 | -51.0% | 201,485 | -52.9% | 0.01% | -52.4% |
Q3 2021 | $44,006,000 | +15.8% | 428,028 | -0.9% | 0.02% | +16.7% |
Q2 2021 | $37,989,000 | +5.6% | 431,888 | +16.7% | 0.02% | -5.3% |
Q1 2021 | $35,981,000 | -24.2% | 370,056 | -12.6% | 0.02% | -34.5% |
Q4 2020 | $47,478,000 | +20.2% | 423,351 | -0.6% | 0.03% | +7.4% |
Q3 2020 | $39,484,000 | +4.7% | 425,940 | -11.9% | 0.03% | -6.9% |
Q2 2020 | $37,700,000 | +83.7% | 483,337 | +37.7% | 0.03% | +61.1% |
Q1 2020 | $20,525,000 | -13.3% | 350,963 | +18.8% | 0.02% | +20.0% |
Q4 2019 | $23,665,000 | +6.6% | 295,426 | -2.2% | 0.02% | 0.0% |
Q3 2019 | $22,196,000 | -24.3% | 302,128 | -2.8% | 0.02% | -11.8% |
Q2 2019 | $29,325,000 | +126.0% | 310,910 | +91.8% | 0.02% | +112.5% |
Q1 2019 | $12,974,000 | +61.6% | 162,099 | +8.8% | 0.01% | +33.3% |
Q4 2018 | $8,029,000 | -70.4% | 148,957 | -57.1% | 0.01% | -25.0% |
Q3 2018 | $27,083,000 | -46.0% | 346,967 | -56.1% | 0.01% | -42.9% |
Q2 2018 | $50,138,000 | +254.8% | 789,860 | +412.5% | 0.01% | +100.0% |
Q1 2018 | $14,131,000 | +65.5% | 154,122 | +36.1% | 0.01% | +40.0% |
Q4 2017 | $8,540,000 | +118.4% | 113,282 | +101.6% | 0.01% | +66.7% |
Q3 2017 | $3,911,000 | -5.8% | 56,180 | -31.5% | 0.00% | 0.0% |
Q2 2017 | $4,150,000 | +175.2% | 81,989 | +116.9% | 0.00% | +200.0% |
Q1 2017 | $1,508,000 | +104.6% | 37,798 | +43.2% | 0.00% | 0.0% |
Q4 2016 | $737,000 | -31.3% | 26,403 | -27.1% | 0.00% | 0.0% |
Q3 2016 | $1,073,000 | -20.4% | 36,231 | -45.7% | 0.00% | 0.0% |
Q2 2016 | $1,348,000 | +14.8% | 66,716 | +2.4% | 0.00% | 0.0% |
Q1 2016 | $1,174,000 | -62.3% | 65,165 | -44.9% | 0.00% | -50.0% |
Q4 2015 | $3,112,000 | -20.7% | 118,247 | -35.7% | 0.00% | -33.3% |
Q3 2015 | $3,924,000 | +2663.4% | 183,971 | +3299.9% | 0.00% | – |
Q2 2015 | $142,000 | – | 5,411 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 559,381 | $41,098,000 | 15.69% |
Casdin Capital, LLC | 940,000 | $69,061,800,000 | 7.15% |
Ghost Tree Capital, LLC | 325,000 | $23,878,000 | 6.08% |
CADIAN CAPITAL MANAGEMENT, LP | 1,418,704 | $104,232,000 | 4.96% |
DAFNA Capital Management LLC | 123,218 | $9,053,000 | 3.40% |
BVF INC/IL | 437,565 | $32,148,000 | 3.38% |
Opaleye Management Inc. | 105,000 | $7,714,000 | 2.79% |
Cormorant Asset Management, LP | 493,000 | $36,221,000 | 2.20% |
Novo Holdings A/S | 170,667 | $12,539,000 | 2.15% |
Artal Group S.A. | 600,000 | $44,082,000 | 1.77% |